Skip to main content

Table 1 Characteristics of participants categorized by metabolic syndrome and NAFLD status

From: The combined effect of non-alcoholic fatty liver disease and metabolic syndrome on colorectal carcinoma mortality: a retrospective in Chinese females

Characteristics Metabolic syndrome (−) Metabolic syndrome (+)
NAFLD (−) NAFLD (+) NAFLD (−) NAFLD (+)
Total number 382 (67.3) 186 (32.7) 66 (33.7) 130 (66.3)
Age at diagnosis (years) 50.02 ± 10.31 51.21 ± 11.96 49.92 ± 12.11 51.82 ± 12.31
BMI (kg/m2) 22.42 ± 4.07 22.96 ± 4.26 24.81 ± 3.49 25.92 ± 4.23
SBP (mmHg) 116.67 ± 20.27 120.58 ± 22.32 132.31 ± 20.12 133.32 ± 20.21
DBP (mmHg) 76.62 ± 10.31 74.91 ± 11.31 77.91 ± 9.91 78.31 ± 10.02
Triglycerides (mmol/L) 1.54 ± 1.87 1.62 ± 1.71 2.21 ± 1.55 2.52 ± 1.81
HDL (mmol/L) 1.20 ± 0.312 1.28 ± 0.323 1.32 ± 0.372 1.33 ± 0.298
LDL (mmol/L) 2.52 ± 1.19 2.61 ± 1.21 2.48 ± 1.02 2.50 ± 0.98
Fasting glucose (mmol/L) 5.01 ± 3.11 5.09 ± 2.76 5.39 ± 3.51 5.50 ± 3.42
CEA (ng/ml) 21.0 ± 101.4 22.7 ± 102.1 23.2 ± 98.7 22.7 ± 101.0
Differentiation
 Well/moderate 310 (81.2) 149 (80.1) 55 (83.3) 102 (78.5)
 Poorly 72 (18.8) 37 (19.9) 11 (16.7) 28 (21.5)
Stage
 I 68 (17.8) 41 (22.0) 11 (16.7) 21 (16.2)
 II 164 (42.9) 87 (46.7) 25 (37.8) 47 (36.2)
 III 150 (39.3) 58 (31.2) 30 (45.5) 62 (47.6)
Location
 Ascending, transverse, and descending 102 (26.7) 40 (21.5) 22 (33.3) 36 (27.7)
 Sigmoid 108 (28.3) 54 (29.0) 17 (25.8) 32 (24.6)
 Rectum 172 (45.0) 92 (49.5) 27 (40.9) 62 (47.7)
  1. NAFLD non-alcoholic fatty livers disease, BMI body mass index, SBP systolic blood pressure, DBP diastolic blood pressure, HDL high-density lipoprotein, LDL low-density lipoprotein
  2. Data are expressed as mean ± standard deviation and n (%)